.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Cerilliant
Daiichi Sankyo
Fish and Richardson
Medtronic
Accenture
Deloitte
Merck
Johnson and Johnson

Generated: February 25, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Patent: 01125020

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Sprout PharmsADDYIflibanserinTABLET;ORAL022526-001Aug 18, 2015RXYesYes➤ Sign Up➤ Sign UpUSE OF FLIBANSERIN OR A PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF TO TREAT HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD)
Sprout PharmsADDYIflibanserinTABLET;ORAL022526-001Aug 18, 2015RXYesYes➤ Sign Up➤ Sign UpUSE OF FLIBANSERIN OR A PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF TO TREAT HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD)
Sprout PharmsADDYIflibanserinTABLET;ORAL022526-001Aug 18, 2015RXYesYes➤ Sign Up➤ Sign UpUSE OF FLIBANSERIN OR A PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF TO TREAT HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD)
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist